The US FDA recently approved ceftaroline fosamil (ceftaroline) for the treatment of acute bacterial skin and soft structure infections (ABSSSIs) and community-acquired pneumonia. In 2010 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback